The YLR108C antibody is a specific immunological reagent designed to detect the protein product of the YLR108C gene in yeast (Saccharomyces cerevisiae). This gene encodes a nuclear-localized protein of unknown function, which has been implicated in respiration regulation and glucose-mediated metabolic transitions . The antibody is typically used in Western blotting, immunofluorescence microscopy, or protein immunoprecipitation to study YLR108C expression, localization, and functional interactions .
YLR108C functions as a repressor of respiration, modulating yeast's transition from fermentation to oxidative phosphorylation during nutrient shifts. When glucose is depleted, yeast upregulates respiration to utilize alternative carbon sources (e.g., ethanol, galactose). Deletion or reduced expression of YLR108C accelerates this metabolic switch, shortening the lag phase and enhancing biomass production under changing nutrient conditions . This regulatory role is critical for industrial applications, such as brewing or biofuel production, where yeast efficiency is optimized .
| Nutrient Condition | YLR108C Expression | Phenotypic Impact |
|---|---|---|
| Glucose present | High | Represses respiration |
| Glucose depletion | Repressed | Shortens lag phase |
| Ethanol/maltose | Induced | Delays metabolic shift |
The antibody is employed in diverse studies to elucidate YLR108C's role in:
Subcellular localization: Confocal microscopy reveals nuclear enrichment, with minor cytoplasmic foci (Table 1) .
Protein interaction networks: Co-immunoprecipitation identifies partners in respiratory regulation .
Industrial strain optimization: Engineering YLR108C expression reduces alcohol content in fermentation products .
| Compartment | Localization Percentage |
|---|---|
| Nucleus | 63.4% |
| Cytoplasm | 29.5% |
| Endoplasmic Reticulum | 4.1% |
| Golgi | 2.0% |
| Lipid Particles | 1.0% |
Glucose-dependent regulation: YLR108C is induced in glucose-rich media and repressed during ethanol/maltose transitions .
Lag phase reduction: Deletion of YLR108C reduces lag time by 30–50% in ethanol-grown cultures (Figure 10, ).
The YLR108C antibody demonstrates:
KEGG: sce:YLR108C
STRING: 4932.YLR108C
YLR108C is a non-essential yeast protein of unknown function that localizes primarily to the nucleus. Its significance stems from several key characteristics. First, protein abundance increases specifically in response to DNA replication stress, suggesting a potential role in DNA damage response pathways . Second, YLR108C has a paralog, YDR132C, that arose from whole genome duplication, indicating possible functional redundancy within cellular systems . Third, its localization patterns change under various stress conditions, making it a valuable marker for studying cellular stress responses. For researchers, YLR108C represents an excellent model for investigating stress-responsive nuclear proteins with potential roles in genome maintenance.
DNA replication stress significantly upregulates YLR108C protein abundance. According to the cellular GFP intensity data, YLR108C shows a nearly two-fold increase in expression when cells are treated with hydroxyurea (HU), a chemical that induces replication stress . Specifically, mean cell GFP intensity increased from baseline values of 8.6-9.5 (×10⁻⁴) in wild-type conditions to 17.1 (×10⁻⁴) at 80 minutes of HU treatment, with sustained elevation at 14.8 (×10⁻⁴) at 120 minutes . This substantial and persistent increase suggests that YLR108C plays a specific role in the cellular response to replication stress, possibly functioning in DNA damage repair, checkpoint activation, or stress signaling pathways.
For optimal immunodetection of YLR108C, researchers should consider the protein's subcellular distribution across multiple compartments while maintaining structural integrity. Based on localization data showing nuclear predominance with minor distributions in the ER, cytoplasm, and membrane-bound organelles , a two-step fixation protocol is recommended. Begin with a mild formaldehyde fixation (3.7% for 15-20 minutes) to preserve protein-protein interactions, followed by a brief permeabilization with 0.1% Triton X-100. For cases requiring detection of the small cytoplasmic fraction, methanol fixation (-20°C for 5 minutes) can provide superior results by better preserving cytoplasmic proteins. When designing co-localization experiments, consider that YLR108C shows enrichment in the endoplasmic reticulum upon stress (enrichment score of 20.82 in certain conditions) , which may require specialized fixation protocols to maintain ER morphology.
Distinguishing between YLR108C and its paralog YDR132C requires careful antibody selection and validation strategies. Since these proteins arose from whole genome duplication , they likely share significant sequence homology. For antibody-based discrimination:
Target unique epitopes: Design or select antibodies against regions with the greatest sequence divergence between the paralogs, typically in non-conserved loops or termini.
Validation controls: Always include validation using knockout strains for both YLR108C and YDR132C individually. Particularly, ensure signal absence in YLR108C-deletion strains while confirming detection in wild-type samples.
Cross-reactivity testing: Perform Western blots with recombinant versions of both proteins to quantify potential cross-reactivity.
Competitive binding assays: Use sequential immunoprecipitation with paralog-specific antibodies to determine binding specificity and potential cross-reactivity thresholds.
Microscopy validation: Compare localization patterns, as subtle differences in distribution between the paralogs may help confirm antibody specificity.
To maximize YLR108C antibody sensitivity, sample preparation techniques should account for the protein's nuclear predominance and its increased abundance during DNA replication stress . For optimal detection:
Cell synchronization: Since YLR108C abundance increases during replication stress, synchronizing cells at S-phase using hydroxyurea treatment (80-120 minutes optimal based on intensity data) can significantly increase detection sensitivity .
Nuclear enrichment: Employing nuclear extraction protocols will concentrate the target protein, as GFP-fusion studies confirm nuclear localization . For detecting the lower-abundance cytoplasmic fraction, additional processing may be required.
Epitope retrieval: If using fixed samples for immunohistochemistry, heat-induced epitope retrieval in citrate buffer (pH 6.0) for 20 minutes improves antibody accessibility to nuclear antigens.
Detergent selection: For immunoprecipitation, CHAPS or digitonin (0.5-1%) preserves protein-protein interactions better than stronger ionic detergents.
Blocking optimization: BSA (3-5%) with 0.1% Tween-20 typically provides optimal signal-to-noise ratio for nuclear yeast proteins.
YLR108C appears in the "Other" category of proteins that display altered localization or intensity when SUMO chain formation is disrupted in yeast . This suggests YLR108C may be directly SUMOylated or indirectly affected by the SUMO system. When working with YLR108C antibodies in the context of SUMOylation research:
Detecting SUMOylated forms: YLR108C may exist in multiple SUMOylated states, creating a ladder-like pattern on Western blots rather than a single band. Use SUMO-specific antibodies in co-immunoprecipitation experiments to confirm modification.
Sample preparation considerations: Include N-ethylmaleimide (NEM, 20mM) in lysis buffers to inhibit SUMO proteases that rapidly remove SUMO modifications during extraction.
Antibody epitope accessibility: If your antibody targets regions near potential SUMOylation sites, detection efficiency may decrease for modified versions. Use multiple antibodies targeting different epitopes to ensure comprehensive detection.
Stress-dependent modifications: Since SUMO modification often changes under stress conditions, and YLR108C responds to replication stress , compare SUMOylation patterns between normal growth and DNA damage conditions (hydroxyurea treatment).
Functional impact: When interpreting results, consider that SUMO modification may alter YLR108C's interactions, localization, or stability, potentially explaining its altered behavior in smt3 allR mutants (SUMO chain deficient) .
Rigorous validation of YLR108C antibody specificity requires a comprehensive set of controls:
Genetic validation: YLR108C is non-essential , enabling the use of knockout strains (ylr108c∆) as negative controls. Complete signal absence in these strains confirms specificity.
Overexpression controls: Compare signal intensity between wild-type and YLR108C-overexpressing strains to confirm signal proportionality to protein levels.
Competitive peptide blocking: Pre-incubate antibody with the immunizing peptide before application to verify that signal reduction occurs specifically.
Orthogonal detection methods: Correlate antibody detection with mass spectrometry or with GFP signal in YLR108C-GFP fusion strains .
Paralog cross-reactivity assessment: Test against purified YDR132C (the paralog) to quantify potential cross-reactivity .
Stress condition validation: Since YLR108C abundance increases during replication stress , compare antibody signal between normal and hydroxyurea-treated samples to confirm the expected upregulation pattern.
Isotype control: Include appropriate isotype control antibodies to distinguish non-specific binding from true signal.
Optimizing immunoprecipitation (IP) of YLR108C complexes requires special consideration of its nuclear localization and potential stress-dependent interactions:
Nuclear extraction optimization: Since YLR108C is predominantly nuclear , use nuclear extraction buffers (e.g., high-salt extraction with 420mM NaCl followed by dilution) to efficiently solubilize the protein while maintaining nuclear complex integrity.
Crosslinking considerations: For capturing transient interactions, employ reversible protein crosslinkers like DSP (dithiobis(succinimidyl propionate)) at 0.5-2mM for 30 minutes before lysis.
Buffer composition: Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) and deacetylase inhibitors (sodium butyrate, trichostatin A) to preserve post-translational modifications that may mediate interactions.
Detergent selection: For nuclear proteins involved in chromatin processes, CHAPS (0.3-1%) or digitonin (0.5%) often preserve complexes better than stronger detergents like SDS or Triton X-100.
Antibody orientation: Compare results using antibodies targeting different epitopes of YLR108C, as some regions may be obscured in certain protein complexes.
Stress condition comparison: Since YLR108C responds to replication stress , perform parallel IPs from normal and stressed cells (e.g., hydroxyurea treatment) to identify stress-specific interaction partners.
Sequential IP approach: For stringent complex purification, perform tandem IPs using different antibodies or tagged versions of YLR108C.
Interpreting YLR108C localization changes requires careful analysis of quantitative localization data across different cellular compartments and stress conditions. The localization enrichment scores from the dataset reveal striking compartment-specific responses:
| Compartment | Normal Condition | Under Stress | Interpretation |
|---|---|---|---|
| Nucleus | Baseline presence | Increased signal | Primary site of function during stress response |
| Endoplasmic Reticulum | Score: 2.43 | Score: 20.82 under specific stress | Dramatic ER recruitment suggests potential role in ER stress response |
| Cytoplasm | Score: 0.51 | Score: 5.73 under specific stress | Moderate increase may indicate cytoplasmic signaling function |
| Cytoplasmic Foci | Score: 1.13 | Variable depending on stress | Potential stress granule or P-body association |
When analyzing localization data, consider that dramatic increases in ER localization (20.82 enrichment score) may indicate a secondary function in protein quality control or ER stress response pathways. The simultaneous increase in both nuclear and cytoplasmic signals suggests shuttle behavior rather than simple relocalization. For rigorous interpretation, researchers should:
Normalize compartment-specific signals to total cellular protein
Track temporal dynamics through stress induction and recovery
Compare localization patterns with known markers of specific stress bodies (P-bodies, stress granules)
Correlate localization changes with functional readouts (e.g., DNA damage markers)
When analyzing YLR108C in multiprotein complexes, researchers should consider several critical factors based on its characteristics and behavior:
DNA damage response context: YLR108C appears in the same functional group as several DNA repair proteins in SUMO chain studies , suggesting potential interactions with repair machinery. When analyzing complex data, look specifically for co-precipitation with known repair factors like RAD52, MRE11, or XRS2.
Paralog compensation: Given that YLR108C has a paralog (YDR132C) , complex composition may vary in single knockout strains due to compensation. Always compare complex components between wild-type, ylr108c∆, and ydr132c∆ strains.
Post-translational modification influence: Since YLR108C is potentially regulated by SUMOylation , the modification state may determine complex assembly. Use antibodies specific to modified forms to distinguish complex subpopulations.
Stress-dependent interactions: Given YLR108C's response to replication stress , complex composition likely changes dramatically under stress conditions. Perform parallel analyses under normal and stress conditions, with temporal resolution during stress induction.
Nuclear subcompartment specificity: Within the nucleus, YLR108C may associate with distinct subcompartments (nucleolus, nuclear pore, chromatin). Use nuclear subfractionation or proximity labeling approaches to determine precise sublocalization of complexes.
Data integration approach: Integrate your proteomic data with published high-throughput datasets, particularly Table 1 from the SUMO chain function study , which categorizes potential functional relationships.
Reconciling inconsistencies in YLR108C antibody results requires systematic troubleshooting and data integration approaches:
Epitope accessibility variations: YLR108C undergoes significant localization changes under stress conditions, with enrichment scores ranging from 2.43 to 20.82 in certain compartments . These dramatic shifts may affect epitope exposure differently across conditions. Test multiple antibodies targeting different regions of the protein.
Post-translational modification interference: Given YLR108C's potential regulation by the SUMO system , modifications may mask epitopes in condition-specific manners. Compare results using antibodies that recognize different epitopes, and use modification-specific detection methods.
Expression level reconciliation: GFP-intensity data shows that YLR108C levels increase nearly two-fold during replication stress (from ~9.0 to 17.1 × 10⁻⁴) . Ensure that quantification methods account for these baseline differences when comparing conditions.
Extraction efficiency variation: The shift between cellular compartments (nucleus, ER, cytoplasm) under different conditions means that standard extraction protocols may have variable efficiency. Develop compartment-specific extraction protocols and validate recovery.
Integrative analysis approach: When facing inconsistencies, implement a three-pronged verification approach:
Orthogonal detection methods (mass spectrometry, RNA levels)
Multiple antibodies targeting different epitopes
Genetic controls (tagged versions, deletion strains)
Standardization using internal reference proteins: Select compartment-specific housekeeping controls that remain stable under your experimental conditions to normalize signals across experiments.
Several emerging technologies show particular promise for advancing YLR108C antibody-based research:
Proximity labeling approaches: TurboID or APEX2 fusions to YLR108C would allow in vivo biotinylation of proximal proteins, capturing even transient interactions that occur during stress responses. This is particularly valuable given YLR108C's dynamic localization patterns across cellular compartments .
Live-cell antibody fragments: Cell-permeable nanobodies or scFvs against YLR108C would enable real-time tracking of native protein without GFP fusion, potentially revealing dynamics not captured in fixed-cell imaging.
Quantitative super-resolution microscopy: Techniques like STORM or PALM combined with YLR108C antibodies could resolve its precise subnuclear localization and potential association with specific chromatin domains during replication stress.
Antibody-guided CRISPR screening: Conjugating YLR108C antibodies with CRISPR effectors (CRISPRa/CRISPRi) would enable targeted genetic screening specifically in cells/regions where YLR108C is expressed or localized.
Single-cell antibody-based proteomics: Emerging techniques combining antibody detection with single-cell resolution would help characterize the heterogeneity in YLR108C expression and localization, particularly relevant given the subpopulation effects observed in SUMO chain mutants .
Deep mutational scanning with antibody readouts: Combining systematic mutagenesis of YLR108C with antibody-based detection would map functional domains and interaction interfaces with high resolution.
Recent research on SUMO chain functions reveals potential new dimensions to YLR108C biology that warrant further investigation:
Chromatin organization connection: SUMO chain function has been implicated in maintaining higher-order chromatin structure . YLR108C's nuclear localization and appearance in SUMO chain mutant screens suggest it may participate in chromatin organization, particularly during replication stress.
Osmotic and environmental stress response: SUMO chain mutants display characteristics of activated environmental stress responses, including vacuolar fragmentation and altered mitochondrial function . YLR108C's dynamic localization across compartments suggests it might function at the interface between nuclear stress signaling and cytoplasmic/organellar responses.
Cell cycle regulation: SUMO chain mutants show significant increases in cell volume and DNA repair foci . YLR108C's response to replication stress might link it to cell cycle checkpoint controls, suggesting potential roles in coordinating replication with cell growth.
Pleiotropic phenotypes: The SUMO chain study revealed that disruption of SUMO chain assembly produces a pleiotropic cell population with several different physiological defects . This suggests YLR108C may have different functions in subpopulations of cells depending on their physiological state.
Research approach implications: Future YLR108C studies should specifically examine its behavior in relation to known SUMO substrates in Table 1 , particularly those in DNA replication/repair categories, which showed significant localization changes in SUMO chain mutants.
YLR108C antibodies offer several promising applications in functional genomics that leverage its unique properties:
Stress response pathway mapping: Since YLR108C abundance increases during replication stress , antibodies can serve as endogenous markers for monitoring stress activation in high-throughput genetic or chemical screens.
Chromatin association profiling: Combining YLR108C antibodies with ChIP-seq could map its genomic binding sites, potentially revealing roles in regulating specific genes or genomic regions during stress.
Synthetic genetic interaction screening: Using YLR108C antibody readouts (localization/abundance) as phenotypic markers in systematic genetic interaction screens would identify functional relationships, particularly with genes in the SUMO pathway .
Organellar stress response characterization: Given YLR108C's dramatic relocalization to the ER under certain conditions (enrichment score of 20.82) , antibodies could serve as tools to dissect the coordination between nuclear events and ER processes.
Evolutionary conservation studies: Applying YLR108C antibodies across related yeast species could trace functional evolution of stress responses, particularly valuable given its paralog relationship with YDR132C from whole genome duplication .
Multi-dimensional phenotypic screening: Combining YLR108C antibody readouts with other markers in high-content imaging would create rich phenotypic profiles for characterizing genetic or chemical perturbations affecting DNA replication and repair pathways.